BASF boosts API, excipient prices; Pfizer sells Capsugel to investor;

> BASF has increased the price of its APIs and drug excipients by 10 percent. Story

> Pfizer is selling its capsule-making unit, Capsugel, for $2.375 billion in cash to investment firm Kohlberg Kravis Roberts & Co.  Release

> India has approved a life sentence for anyone convicted of making fake drugs and distributing them in Nigeria. Item

> The Process Analytical Technology initiative will drive demand for instrumentation, says Frost and Sullivan. Story

> China's drug regulator, focused on improving drug safety, quality, and effectiveness, is turning to FDA regulations as a guide. Blog

> A top 10 drugmaker has selected Payne Security holographic tear tape for counterfeit protection and tamper evidence. Article

> For the second time in six years, Mylan Pharmaceuticals is expanding its distribution center in southeast Greensboro, NC, adding 162,400 square feet of space. News

> Supply chain service provider Tracelink says that half of Catalent Pharma Solutions' U.S. manufacturing sites have been added to its network. Report

> The consultancy Life Science Link has signed a deal with QuaDPharma for small scale pharmaceutical manufacturing services at Niagara Medical Campus in New York. Article

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.